HAVCR2 and rheumatoid arthritis: Our RA patients, particularly those with moderate-to-severe NAFLD, showed elevated levels of soluble TIM-3 (sTIM-3), which could block membrane-bound TIM-3 expressed on T cells and thus restore proliferation and activation of these immune cells (51).